China Sexual Dysfunction Treatment Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the China Sexual Dysfunction Treatment Market was valued at USD 371.0 million in 2025 and is projected to reach USD 511.68 million by 2032, growing at a CAGR of approximately 4.7% during 2026–2032.
China Sexual Dysfunction Treatment Market Highlights
| Report Metric | Details |
| Report Name | China Sexual Dysfunction Treatment Market |
| Market Size 2025 | USD 371.0 million |
| Market Size 2032 | USD 511.68 million |
| Absolute Growth 2025–2032 | USD 140.68 million |
| CAGR 2026–2032 | 4.7% |
| Peak Annual Growth | 6.9% in 2029 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Treatment Type, 2025 | PDE5 Inhibitors (46% share) |
| Leading Gender Focus, 2025 | Male (43% share) |
| Leading Administration Mode, 2025 | Oral (40% share) |
| Leading End User, 2025 | Clinics & Pharmacies (40% share) |
| Fastest-Growing Treatment Type | Counseling & Therapy (5.9% CAGR) |
| Fastest-Growing Gender Focus | Female (7.3% CAGR) |
| Fastest-Growing Administration Mode | Transdermal/Injectable (6.3% CAGR) |
| Fastest-Growing End User | Hormonal Therapy Centers (7.1% CAGR) |
| Growing Sector | Hormonal Therapy Centers |
| Key End Users | Clinics & Pharmacies, Urologists & Gynecologists, Hormonal Therapy Centers, Mental Health Facilities |
China Sexual Dysfunction Treatment Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Below, each year's estimated growth is shown next to the factor that most influenced it.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 5.6 | The prevalence of erectile dysfunction highlighted the need for effective treatments. |
| 2023 | 4.0 | The National Sexual Health Awareness Campaign increased public interest in treatment options. |
| 2024 | 5.2 | Rising demand for counseling services improved access to psychological support for patients. |
| 2025 | 3.2 | Growth in urban healthcare facilities continued to support treatment availability. |
| 2026 | 4.6 | Hormone Replacement Therapy gained traction among older adults in urban areas. |
| 2027 | 6.7 | Increased awareness of sexual health issues led to higher treatment uptake. |
| 2028 | 3.4 | The introduction of new treatment guidelines encouraged better patient management. |
| 2029 | 6.9 | The growing number of urologists improved access to specialized care. |
| 2030 | 3.3 | Online counseling services became more popular, providing easier access to support. |
| 2031 | 6.2 | The ongoing public awareness campaigns maintained interest in sexual health. |
| 2032 | 1.9 | The National Mental Health Action Plan continues to integrate sexual health into overall well-being. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
China Sexual Dysfunction Treatment Market Synopsis
The Sexual Dysfunction Treatment Market in China encompasses a range of therapies designed to enhance sexual health through pharmaceuticals and counselling. With a population of approximately 1.4 billion, many individuals face sexual dysfunction, which fuels the demand for effective treatments. The market is growing as urban healthcare facilities improve access to these services. Initiatives such as the National Sexual Health Awareness Campaign promote education and treatment options, driving further investment in this sector.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Growing prevalence of erectile dysfunction among men | Driver | High | PDE5 Inhibitors |
| Increased adoption of hormone therapies in urban areas | Driver | High | Hormone Replacement Therapy |
| Rising demand for specialized counseling services | Opportunity | High | Counseling & Therapy |
| Expansion of clinics and pharmacies offering treatments | Opportunity | High | Clinics & Pharmacies |
| Limited awareness in rural areas | Restraint | Medium | Counseling & Therapy |
| Stigma surrounding sexual health issues | Restraint | Medium | PDE5 Inhibitors |
| Shortage of trained specialists in rural regions | Challenge | High | Urologists & Gynecologists |
| Delays in regulatory approvals for new treatments | Challenge | Medium | Hormone Replacement Therapy |
Evaluation of Drivers in China Sexual Dysfunction Treatment Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| High prevalence of erectile dysfunction | PDE5 Inhibitors | Approximately 26.8% of men in China experience erectile dysfunction, driving demand for treatments. |
| Increased urban adoption of hormone therapies | Hormone Replacement Therapy | Urban centres are seeing a growing number of older adults seeking hormone treatments. |
| Rise in online counseling services | Counseling & Therapy | Online counseling usage has surged, providing better access to support post-2020. |
| Expansion of healthcare facilities in urban areas | Clinics & Pharmacies | Urban healthcare facilities are increasing, improving treatment availability and access. |
| Public awareness campaigns promoting sexual health | Counseling & Therapy | The National Sexual Health Awareness Campaign aims to educate the public on treatment options. |
Growth across the Sexual Dysfunction Treatment market in China is anchored in the high prevalence of erectile dysfunction, increased urban adoption of hormone therapies, and a rise in online counseling services. The estimated prevalence of erectile dysfunction among men drives demand for PDE5 inhibitors. Urban areas are witnessing a surge in older adults seeking hormone replacement therapies, particularly in clinics and pharmacies. The rise in online counseling services has improved access to psychological support. Public awareness campaigns are expected to enhance understanding of treatment options, increasing demand for these services.
Evaluation of Restraints in China Sexual Dysfunction Treatment Market
The table below lists the restraints and the evidence behind each.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Limited awareness of treatment options in rural areas | Counseling & Therapy | A large portion of the population lacks knowledge about available treatments, hindering access. |
| Stigma surrounding sexual health issues | PDE5 Inhibitors | Cultural barriers prevent many individuals from seeking help for sexual dysfunction. |
| Shortage of trained specialists in rural regions | Urologists & Gynecologists | There are over 3,000 urologists, but many are concentrated in urban areas, limiting rural access. |
| Delays in regulatory approvals for new treatments | Hormone Replacement Therapy | Regulatory processes have not fully resolved delays, affecting market entry for new therapies. |
| High costs of some treatments | PDE5 Inhibitors | Affordability issues can deter patients from pursuing necessary therapies. |
China Sexual Dysfunction Treatment Market Challenges
The China Sexual Dysfunction Treatment Market encounters several practical issues, starting with consumers struggling with the high costs of PDE5 inhibitors, which can restrict access to necessary treatments, especially in rural regions. Many clinics lack ISO 9001 certification, leading to challenges in technology adoption that can compromise care quality and patient trust. Supply chain disruptions arise from dependence on imported pharmaceuticals, resulting in delays in treatment availability, with some patients waiting over three months for essential medications. A shortage of trained professionals, particularly in rural areas, hampers the effective delivery of sexual health services, ultimately impacting patient outcomes.
Trends in the China Sexual Dysfunction Treatment Market
Below mentioned are some of the trends shaping the China Sexual Dysfunction Treatment Market growth.
- Shift towards Online Counseling Services: Since 2020, online counselling for sexual health issues has become increasingly popular, with a marked rise in usage. This trend reflects evolving attitudes towards mental health and accessibility, enabling more individuals to seek help without stigma.
- Growth in Hormone Replacement Therapy: The adoption of Hormone Replacement Therapy is increasing, especially among older adults in urban centres. This shift is driven by heightened awareness of hormonal imbalances affecting sexual function, leading to greater uptake of treatment.
- Increased Public Awareness Campaigns: A public awareness campaign launched by the Chinese Society of Urology in 2023 aims to destigmatise sexual dysfunction. This initiative educates the public about treatment options, encouraging more individuals to seek assistance.
- Expansion of Specialized Clinics: The number of clinics and pharmacies providing sexual dysfunction treatments is on the rise, particularly in urban areas. This expansion is fuelled by the growing demand for accessible healthcare services, improving treatment availability.
Investment Opportunities in the China Sexual Dysfunction Treatment Market
The following opportunities in the China Sexual Dysfunction Treatment Market pair current demand with a clear way in.
- Growing Demand for Counseling Services: With a large portion of the population experiencing sexual dysfunction, the demand for counseling services is increasing. The National Sexual Health Awareness Campaign highlights the need for more clinics to offer these services.
- Investment in Hormonal Therapy Centers: As Hormone Replacement Therapy adoption rises, there is an opportunity to invest in specialized hormonal therapy centres. Urban areas, particularly among older adults, present a growing market for these services.
- Expansion of Online Treatment Platforms: The rise in online counseling services indicates a gap in the market for digital platforms. Investing in these platforms can cater to the increasing need for accessible sexual health support.
- Development of Educational Programs: With ongoing public awareness campaigns, there is a need for educational programs on sexual health. Collaborating with healthcare providers can help bridge the knowledge gap in rural areas.
Government Initiatives in the China Sexual Dysfunction Treatment Market
In 2023, the Ministry of Health updated the 'Guidelines for the Management of Sexual Dysfunction', emphasising evidence-based treatment protocols. This update builds on the 'Comprehensive Sexual Health Promotion Plan' launched in 2021, aimed at enhancing sexual health education and access to treatments nationwide. The updated guidelines ensure that providers adhere to best practices, improving the quality of care for patients seeking sexual dysfunction treatments.
The National Health Commission supervises the implementation of health promotion initiatives, funding projects to improve sexual health education. Additionally, the Ministry of Health approves new treatment protocols and guidelines to ensure effective management of sexual dysfunction. In 2023, the government allocated funds to enhance access to sexual health services in rural areas, benefiting underserved populations.
Future Insight of the China Sexual Dysfunction Treatment Market
Several forward-looking factors should support the China Sexual Dysfunction Treatment Market in the coming years. The National Sexual Health Awareness Campaign will improve public understanding and encourage more individuals to seek treatment. By 2025, the number of urologists is projected to increase to over 3,500, enhancing access to specialized care. Advances in online counseling platforms will facilitate treatment accessibility for younger demographics. The adoption of Hormone Replacement Therapy will rise, effectively addressing hormonal imbalances among older adults.
Market Segmentation Analysis
The analysis below covers each segmentation, its leading category in 2025 and its fastest-growing category through 2032.
By Treatment Type – PDE5 Inhibitors Dominated, Counseling & Therapy Expected to Grow Fastest
According to Dhaval Chaurasia, Assistant Manager at 6Wresearch, PDE5 Inhibitors accounted for a 46% market share by treatment type in 2025. PDE5 inhibitors command the largest market share in China as they are the primary choice for treating erectile dysfunction, a condition affecting a significant portion of the male demographic. Their widespread prescription is reinforced by established treatment protocols and guidelines from the Chinese Society of Urology. Over 2026–2032, Counseling & Therapy is expected to post the fastest growth, at a CAGR of 5.9%. Counseling and therapy are witnessing rapid growth as more individuals acknowledge the importance of addressing psychological aspects of sexual dysfunction, particularly following the National Sexual Health Awareness Campaign launched in 2023. This initiative has heightened awareness and acceptance of mental health support within the realm of sexual health. Suppliers should focus on enhancing counselling services to meet the growing demand for comprehensive approaches to sexual dysfunction treatment.
By Gender Focus – Male Dominated, Female Expected to Grow Fastest
Male took a 43% share of gender focus in 2025, more than any other category. The male segment dominates the market share as treatments are primarily designed for male sexual dysfunction, which is more prevalent within the population. This focus is highlighted by the estimated 26.8% prevalence of erectile dysfunction, driving strong demand for male-centric therapies. Female is set to record the highest CAGR in this split, 7.3% over 2026–2032. The female segment is experiencing the fastest growth, propelled by increasing awareness of female sexual health issues and a shift towards more inclusive treatment options. This trend presents a significant opportunity for healthcare providers to address the previously overlooked needs of women. Suppliers should implement targeted marketing strategies to effectively engage the growing female segment in the sexual dysfunction treatment market.
By Administration Mode – Oral Dominated, Transdermal/Injectable Expected to Grow Fastest
In 2025, Oral led the administration mode split with a 40% share. Oral administration dominates the market share, as it is the most common and preferred mode for sexual dysfunction treatments, particularly for PDE5 inhibitors. Patients find oral medications convenient and easy to use, contributing to their widespread acceptance. Transdermal/Injectable is projected to grow fastest, at a CAGR of 6.3% during 2026–2032. Transdermal and injectable methods are growing rapidly, especially for hormone therapies, as they offer alternatives for patients who may prefer non-oral options. This growth is facilitated by advancements in delivery methods and increasing awareness of hormone-related treatments. Suppliers should invest in research and development for transdermal and injectable treatments to capture the growing interest in alternative administration modes.
By End User – Clinics & Pharmacies Dominated, Hormonal Therapy Centers Expected to Grow Fastest
With a 40% revenue share in 2025, Clinics & Pharmacies was the largest end user category. Clinics and pharmacies hold the largest market share as they are the primary access points for sexual dysfunction treatments, ensuring patients can easily obtain necessary therapies. The extensive network of over 3,000 urologists further enhances the distribution of these treatments across the country. The quickest growth will come from Hormonal Therapy Centers, forecast to expand at a CAGR of 7.1% between 2026 and 2032. Hormonal therapy centers are the fastest-growing segment, reflecting a rising demand for specialised care in hormone-related treatments, especially among older adults. This growth aligns with the increasing adoption of hormone replacement therapy in urban areas, signalling a shift in treatment preferences. Suppliers should establish partnerships with hormonal therapy centres to leverage the increasing demand for specialised sexual dysfunction treatments.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- China Sexual Dysfunction Treatment Market Outlook
- Market Size of China Sexual Dysfunction Treatment Market, 2025
- Forecast of China Sexual Dysfunction Treatment Market, 2032
- Historical Data and Forecast of China Sexual Dysfunction Treatment Revenues & Volume for the Period 2022 - 2032F
- China Sexual Dysfunction Treatment Market Trend Evolution
- China Sexual Dysfunction Treatment Market Drivers and Challenges
- China Sexual Dysfunction Treatment Price Trends
- China Sexual Dysfunction Treatment Porter's Five Forces
- China Sexual Dysfunction Treatment Industry Life Cycle
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Treatment Type for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By PDE5 Inhibitors for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Hormone Replacement Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Counseling & Therapy for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Device-Based Solutions for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Gender Focus for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Male for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Female for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Both for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Both for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Administration Mode for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Oral for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Transdermal/Injectable for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By In-Person/Online for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Wearable/Implantable for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Clinics & Pharmacies for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Hormonal Therapy Centers for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Mental Health Facilities for the Period 2022 - 2032F
- Historical Data and Forecast of China Sexual Dysfunction Treatment Market Revenues & Volume By Urologists & Gynecologists for the Period 2022 - 2032F
- China Sexual Dysfunction Treatment Import Export Trade Statistics
- Market Opportunity Assessment By Treatment Type
- Market Opportunity Assessment By Gender Focus
- Market Opportunity Assessment By Administration Mode
- Market Opportunity Assessment By End User
- China Sexual Dysfunction Treatment Top Companies Market Share
- China Sexual Dysfunction Treatment Competitive Benchmarking By Technical and Operational Parameters
- China Sexual Dysfunction Treatment Company Profiles
- China Sexual Dysfunction Treatment Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Treatment Type
- PDE5 Inhibitors
- Hormone Replacement Therapy
- Counseling & Therapy
- Device-Based Solutions
By Gender Focus
- Male
- Female
- Both
By Administration Mode
- Oral
- Transdermal/Injectable
- In-Person/Online
- Wearable/Implantable
By End User
- Clinics & Pharmacies
- Hormonal Therapy Centers
- Mental Health Facilities
- Urologists & Gynecologists







